Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued to Let's Talk Health, Inc. on August 6, 2019 concerns drug products, though the specific violations cannot be detailed without access to the full letter text. The company appears to have engaged in practices that prompted FDA regulatory action within the drug product category, but the exact nature of the compliance issues remains unclear due to unavailable subject line information. Additional documentation would be necessary to identify the specific regulatory violations and remedial actions required.